NDC 61755-062

Otarmeni 30000000000000 {GC} per 1 mL injection, solution

On the label: Regeneron Pharmaceuticals, Inc..

United States: 2

Where it's made

FactoryWhereRoleLast FDA inspection
Catalent Maryland, Inc.Harmans, MD, United StatesMakes it Not inspected on record
Regeneron Pharmaceuticals, Inc.Rensselaer, NY, United StatesMakes the active ingredient and tests it Problems found, fixed voluntarilyMar 22, 2024 · 10 inspections
Bioreliance CorporationRockville, MD, United StatesTests it Problems found, fixed voluntarilyJan 29, 2026 · 7 inspections
Brammer Bio MA, LLCPlainville, MA, United StatesTests it Not inspected on record
Charles River Laboratories, Inc.Malvern, PA, United StatesTests it No problems foundJan 20, 2026 · 6 inspections
Eurofins Lancaster Laboratories, LLCLancaster, PA, United StatesTests it Problems found, fixed voluntarilyAug 26, 2025 · 8 inspections
Fisher BioServices Inc.Frederick, MD, United StatesPackages it and labels it No problems foundJun 28, 2019 · 1 inspection
Fisher Clinical Services Inc.Allentown, PA, United StatesPackages it and labels it No problems foundMay 7, 2026 · 5 inspections
Nelson Labs NVLeuven, BelgiumTests it Problems found, fixed voluntarilyApr 30, 2024 · 3 inspections
Primera Analytical Solutions CorporationCranbury, NJ, United StatesTests it Problems found, fixed voluntarilyApr 12, 2024 · 3 inspections

Product details

Generic drug
Lunsotogene Parvec: every company that makes it
Form
injection, solution, intracochlear
Strength
30000000000000 {GC} per 1 mL
Approval
BLA BLA125874
On the market since
Apr 23, 2026
Package NDCs
61755-062-00 61755-062-01 61755-062-99
Official label
DailyMed (National Library of Medicine), updated Apr 27, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?